GENEVA, Nov. 6 -- DAIICHI SANKYO COMPANY, LIMITED filed a patent application (JP2026/016655) for “COMBINATION OF ANTIBODY-DRUG CONJUGATE AND T-CELL-RECRUITING ANTIBODY”. With publication no. WO/2026/230489, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....